Hamps Bio Limited has announced an Extraordinary General Meeting (EGM) scheduled for November 24, 2025, to address a significant corporate governance matter. The meeting, set to take place at 4:00 PM at the company's corporate office in Surat, Gujarat, will focus on the regularization of Ms. Shivali Rajpurohit's appointment as a Non-Executive Independent Director.

Key Details of the EGM

About the Directorial Appointment

Ms. Shivali Rajpurohit was initially appointed as an Additional Director on August 25, 2025. The EGM will consider her regularization as a Non-Executive Independent Director for a five-year term, from August 25, 2025, to August 24, 2030.

Director Profile

Ms. Rajpurohit brings expertise in corporate laws, secretarial compliance, and SEBI regulations. Her experience spans both listed and unlisted entities, making her well-suited for the role of an Independent Director in a publicly traded company.

Compliance and Governance

The company has stated that Ms. Rajpurohit has submitted a declaration of independence, and the Board believes she meets the criteria for appointment as an Independent Director under the Companies Act, 2013. This appointment aligns with Hamps Bio Limited's commitment to maintaining strong corporate governance practices.

Shareholder Participation

Shareholders are encouraged to attend the EGM or appoint proxies if unable to attend personally. The company has made provisions for electronic voting and has sent the EGM notice to shareholders whose email addresses are registered with the company or depository participants.

This EGM and the proposed appointment of Ms. Rajpurohit represent Hamps Bio Limited's ongoing efforts to strengthen its board composition and adhere to regulatory requirements for listed entities.

Hamps Bio Limited, a company listed on the Bombay Stock Exchange (BSE) under the scrip code 544312, has announced a revision to the record date for its proposed bonus equity share issue. The company has changed the record date from September 8, 2025, to September 9, 2025, following communication from the BSE.

Bonus Share Details

The company plans to issue bonus shares in a 1:1 ratio, meaning shareholders will receive:

• One bonus equity share of Rs. 10 each
• For every one existing fully paid-up equity share of Rs. 10 each

This bonus share issuance was approved by shareholders through an ordinary resolution at the company's 18th Annual General Meeting held on August 30, 2025.

Revised Record Date

The revision in the record date was made in response to an email received from the Bombay Stock Exchange on September 5, 2025.

Company Background

Hamps Bio Limited, previously known as Hamps Bio Pvt. Ltd., is identified by the Corporate Identification Number (CIN) L24233GJ2007PLC049692. The company operates two manufacturing units:

1. Unit-1: Located at 2900/112, G.I.D.C. Industrial Estate, Nr. Atul Ltd., Ankleshwar - 393002
2. Unit-2: Situated at Plot No. C1-B-108, Nr- Mama Bhanja Factory, Bhatpore G.I.D.C., Surat, Gujarat, India 394510

Management Statement

Herrik Mountbaton Shah, the Managing Director & Chairman of Hamps Bio Limited, signed the official communication to the BSE regarding the record date revision. The company has requested the stock exchange to acknowledge and update their records accordingly.

Investors and shareholders of Hamps Bio Limited should take note of this revised record date for the upcoming bonus share issue. As always, it is advisable for stakeholders to keep track of official company announcements and consult with financial advisors for any investment-related decisions.